G
PharmaceuticalsMidcap
Glenmark Pharmaceuticals Limited is a global pharmaceutical company engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 54.44 | 36.66 |
| PB Ratio | 6.44 | 5.80 |
| Dividend Yield | 0.12% | 0.59% |
Understand what these metrics mean.
For peer comparison & financials,